N-(6,8-Dimethylimidazo[1,2-a]pyrazin-2-yl)-4-(4-methylpiperazin-1-yl)benzamide

ID: ALA4081789

PubChem CID: 137647660

Max Phase: Preclinical

Molecular Formula: C20H24N6O

Molecular Weight: 364.45

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cn2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)nc2c(C)n1

Standard InChI:  InChI=1S/C20H24N6O/c1-14-12-26-13-18(22-19(26)15(2)21-14)23-20(27)16-4-6-17(7-5-16)25-10-8-24(3)9-11-25/h4-7,12-13H,8-11H2,1-3H3,(H,23,27)

Standard InChI Key:  TVJPLGCKQZRBMI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   29.1784  -18.3463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9357  -18.6785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2626  -17.5261    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.0696  -17.3480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4785  -18.0621    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.3001  -18.0618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7136  -17.3483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2956  -16.6334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.4753  -16.6371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0622  -15.9274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5392  -17.3466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4640  -18.7589    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.7474  -18.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0330  -18.7626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3198  -18.3540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6100  -18.7658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6117  -19.5921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3290  -20.0050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0401  -19.5866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9003  -20.0114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.1834  -19.5972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4716  -20.0113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4706  -20.8371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.1876  -21.2473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9054  -20.8355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7552  -21.2480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7453  -17.5246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  5  1  0
  4  3  2  0
  3  1  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
  7 11  1  0
  1 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 17 20  1  0
 23 26  1  0
 13 27  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4081789

    ---

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Salmonella typhimurium (15756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 364.45Molecular Weight (Monoisotopic): 364.2012AlogP: 2.35#Rotatable Bonds: 3
Polar Surface Area: 65.77Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.74CX LogP: 1.45CX LogD: 0.94
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.77Np Likeness Score: -1.47

References

1. Pinard E, Green L, Reutlinger M, Weetall M, Naryshkin NA, Baird J, Chen KS, Paushkin SV, Metzger F, Ratni H..  (2017)  Discovery of a Novel Class of Survival Motor Neuron 2 Splicing Modifiers for the Treatment of Spinal Muscular Atrophy.,  60  (10): [PMID:28441483] [10.1021/acs.jmedchem.7b00406]

Source